SlideShare a Scribd company logo
Applications of
Microbiolgical Data
Tim Sandle
Microbiology information
resource:
http://www.pharmamicroresources.com/
Introduction
 Distribution of microbiological data
 Use of trend charts
 Calculation of warning and action
levels
Introduction
 Examples from environmental
monitoring and water testing
 Broad and illustrative overview
 Written paper with more detail
Distribution of microbiological data
 Why study distribution?
• Impact on sampling
• Impact on trending
• Impact upon calculation of warning and
action levels
Distribution
 Most statistical methods are based
on normal distribution, and yet….
 Most microbiological data does NOT
follow normal distribution
Distribution
 Micro-organisms, such as those in a
typical, free-flowing water system,
follow Poisson distribution
 For example…
Distribution
S1 S2 S3
S4 S5
Where S = sample
= micro-organism
Distribution
 And microbial counts tend to be
skewed (or positive or negative
exponential distribution)
 For example, a Water-for-Injection
system…
Distribution
Typical distribution of micro-organisms in WFI
0
50
100
150
200
250
300
350
1 2 3 4 5 6 7
Count (cfu / 100 ml)
Numberofsamples
Distribution
 So, what can we do about it?
Skewed question mark
Distribution
 Well:
a) Use complex calculations and
Poisson distribution tables, or
b) Attempt to transform then data
 We’ll go for the second option
Distribution
 A general rule is:
• For low count data e.g. Grade A
monitoring and WFI systems, take the
square root
• For higher count data, e.g. Grade C and
D environmental monitoring or a
purified water system, convert the data
into logarithms
Distribution
 For example, some counts from a
WFI system:
Distribution
 When the data is examined for its
distribution, using a simple ’blob’
chart:
CI for Mean
0 2 4 6 8
Count
Distribution
 Whereas if the square root is taken:
Distribution
 We move closer to normal
distribution:
CI for Mean
0 0.5 1 1.5 2 2.5 3
Count
Distribution
 Logarithms work in a similar way for
higher counts
 Remember to add ‘+1’ to zero counts
(and therefore, +1 to all counts)
Trend Analysis
 There is no right or wrong approach
 There are competing systems
 This presentation focuses on two
approaches, both described as
‘control charts’:
• The cumulative sum chart
• The Shewhart chart
Trend Analysis
 Control charts form part of the
quality system
 They can be used to show:
• Excessive variations in the data
• How variations change with time
• Variations that are ‘normally’ expected
• Variations that are unexpected, i.e.
something unusual has happened
Trend Analysis
 Control charts need:
• A target value, e.g. last year’s average
• Monitoring limits:
 Upper limit
 Lower limit
 Control line / mean
 So the data can be monitored over time and
in relation to these limits
Trend Analysis
 Of these,
• The warning limit is calculated to represent a
2.5% chance
• The action level is calculated to represent a
0.1% chance
• So, if set properly, most data should remain
below these limits
• These assumptions are based on NORMAL
DISTRIBUTION
• Various formula can be used to set these or
validated software
Trend Analysis
 Cumulative sum chart (cusum)
• Suitable for large quantities of low count
data. It is very sensitive to small shifts
• Shows shifts in the process mean
 Shewhart chart
• Suitable for higher count data. It shows
large changes more quickly.
Trend Analysis
 Cusums
• Harder to interpret
• Displays the cumulative sum of a rolling
average of three values and plots these
in comparison with the target value
• The direction and steepness of the slope
are important
• Significant changes are called ‘steps’
• V-masks can be used as a prediction to
the future direction
Trend Analysis
 For example, a Grade B cleanroom
 Contact (RODAC) plates are
examined
 A target of 0.2 cfu has been used,
based on data from the previous
year
Trend Analysis
Trend Analysis
 Shewhart charts
• Powerful for distinguishing between
special causes and common causes
• Common causes are inherent to the
process and are long-term
• Special causes are where something has
changed and maybe of a long or short
term
Trend Analysis
 Examples of special causes:
• a) A certain process
• b) A certain outlet
• c) A certain method of sanitisation, etc.
• d) Sampling technique
• e) Equipment malfunction e.g. pumps, UV
lamps
• f) Cross contamination in laboratory
• g) Engineering work
• h) Sanitisation frequencies
Trend Analysis
 For example, a Grade C cleanroom
• Active air-samples are examined
• A target of 1.5, based on historical data
Trend Analysis
Trend Analysis
 The previous charts were prepared
using a statistical software package
 However, MS Excel can also be used
 The next example is of a WFI system
 Notice the data has been converted
by taking the square root of each
value
Trend Analysis
Trend of WFI System over 62 weeks with trend line
-1
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
1
5
9
13
17
21
25
29
33
37
41
45
49
53
57
61
Number of weeks
Sqrootofmeancount/
week
Trend Analysis
 Alternatives:
• Individual Value / Moving Range charts
• Exponentially Weighted Moving Average
charts (EWMA)
• These are useful where counts are NOT
expected, e.g. Grade A environments
• They look at the frequency of intervals
between counts
Trend Analysis
 Summary
Chart Type Advantage Disadvantage
Cumulative sum Cusum charts are more
sensitive to small process
shifts.
Large,
abrupt shifts are not
detected as fast as in a
Shewhart chart.
Shewhart chart Systematic shifts are
easily detected.
The probability of
detecting small shifts fast
is rather small
Limits
 Alert and action levels
 Based on PDA Tech. Report 13 (2001):
• Alert level: a level, when exceeded, indicates
that the process may have drifted from its
normal operating condition. This does not
necessarily warrant corrective action but
should be noted by the user.
• Action level: a level, when exceeded, indicates
that the process has drifted from its normal
operating range. This requires a documented
investigation and corrective action.
Limits
 Why use them?
• Assess any risk (which can be
defined as low, medium or high)
• To propose any corrective action
• To propose any preventative action
Limits
 “Level” is preferable to “Limit”
 Limits apply to specifications e.g.
sterility test
 Levels are used for environmental
monitoring
Limits
 Regulators set ‘guidance’ values e.g.
EU GMP; USP <1116>; FDA (2004)
 These apply to new facilities
 User is expected to set their own
based on historical data
• Not to exceed the published values
• Many references stating this
• Views of MHRA and FDA
Limits
 Things to consider:
• The length of time that the facility has been in
use for
• How often the user intends to use the limits for
(i.e. when the user intends to re-assess or re-
calculate the limits. Is this yearly? Two yearly?
And so on).
• Custom and practice in the user’s organisation
(e.g. is there a preferred statistical technique?)
• They be calculated from an historical analysis
of data.
• Uses a statistical technique.
Limits
 Historical data
• Aim for a minimum of 100 results
• Ideally one year, to account for
seasonal variations
Limits
 Statistical methods:
• Percentile cut-off
• Normal distribution
• Exponential distribution
• Non-parametric tolerance limits
• Weibull distribution
Recommended by PDA Technical
Report, No. 13
Limits
 Assumptions:
a) The previous period was ‘normal’
and that future excursions above the
limits are deviations from the norm
b) Outliers have been accounted for
Limits
 Percentile cut-off
• Good for low count data
• May need to use frequency tables
• May need to round up or down to
nearest whole zero or five
• Warning level = 90th or 95th
• Action level = 95th or 99th
Limits
 Percentile cut-off
• Data is collected, sorted and ranked
 90th percentile means that any future result
that exceeds this is 90% higher than all of
the results obtained over the previous year.
• Refer to PharMIG News Number 3
(2000) for excellent examples.
Limits
 Normal distribution
• Can only be used on data that is
normally distributed!
• Could transform data but inaccuracies
can creep in
• Most data will be one-tailed, therefore
need to adjust 2nd and 3rd standard
deviation
 Warning level = 1.645 + the mean
 Action level = 2.326 + the mean
Limits
 Negative exponential distribution
• Suitable for higher count data
• Warning level: 3.0 x mean
• Action level: 4.6 x mean
Limits
 For all, do a ‘sore thumb’ activity by
comparing to a histogram of the data
 Does it feel right?
Conclusion
 We have looked at:
• Distribution of microbiological data
• Trending
 Cusum charts
 Shewhart charts
• Setting warning and action levels
 Percentile cut-off
 Normal distribution approach
 Negative exponential approach
Conclusion
 Key points:
• Most micro-organisms and microbial
counts do not follow normal distribution
• Data can be transformed
• Inspectors expect some trending and
user defined monitoring levels
• Don’t forget to be professional
microbiologists – it isn’t all numbers!
Just a thought…
 This has been a broad over-view
 If there is merit in a more ‘hands on’
training course, please indicate on
your post-conference questionnaires.
Thank you

More Related Content

What's hot

Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
RavichandraNadagouda
 
Media fill process and validation
Media fill process and validationMedia fill process and validation
Media fill process and validation
paideeksha
 
CAPA
CAPA CAPA
ENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORINGENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING
Srinath Sasidharan
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
Asst Prof SSNAIK ENTO PJTSAU
 
Auditing of microbiological lab
Auditing of microbiological lab Auditing of microbiological lab
Auditing of microbiological lab
KhushbooKunkulol
 
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANINGCONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
Shankar Maind Patil
 
EQUIPMENT VALIDATION : HOT AIR OVEN
EQUIPMENT VALIDATION : HOT AIR OVENEQUIPMENT VALIDATION : HOT AIR OVEN
EQUIPMENT VALIDATION : HOT AIR OVEN
Sagar Savale
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
Bangaluru
 
Gmp
GmpGmp
Depyrogenation by dry heat
Depyrogenation by dry heatDepyrogenation by dry heat
Depyrogenation by dry heat
Tim Sandle, Ph.D.
 
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control LaboratoriesGood Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Sathish Vemula
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
Prakash Ghimire
 
Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)  Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)
Guru Balaji .S
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing Practices
Prashant Tomar
 
Lyophilization 1
Lyophilization   1Lyophilization   1
Lyophilization 1
Asmaira RZ
 
change control
change controlchange control
change control
SrinivasaReddy137
 
Risk Issues Environmental Monitoring of Cleanrooms
Risk Issues Environmental Monitoring of CleanroomsRisk Issues Environmental Monitoring of Cleanrooms
Risk Issues Environmental Monitoring of Cleanroomsnetomoney
 
Pipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifPipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifRana Muhammad Asif
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
anubhavdubey18
 

What's hot (20)

Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Media fill process and validation
Media fill process and validationMedia fill process and validation
Media fill process and validation
 
CAPA
CAPA CAPA
CAPA
 
ENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORINGENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
Auditing of microbiological lab
Auditing of microbiological lab Auditing of microbiological lab
Auditing of microbiological lab
 
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANINGCONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
CONCEPT OF CIP (Clean In Place ) AND FACILITY CLEANING
 
EQUIPMENT VALIDATION : HOT AIR OVEN
EQUIPMENT VALIDATION : HOT AIR OVENEQUIPMENT VALIDATION : HOT AIR OVEN
EQUIPMENT VALIDATION : HOT AIR OVEN
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
 
Gmp
GmpGmp
Gmp
 
Depyrogenation by dry heat
Depyrogenation by dry heatDepyrogenation by dry heat
Depyrogenation by dry heat
 
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control LaboratoriesGood Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
 
Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)  Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing Practices
 
Lyophilization 1
Lyophilization   1Lyophilization   1
Lyophilization 1
 
change control
change controlchange control
change control
 
Risk Issues Environmental Monitoring of Cleanrooms
Risk Issues Environmental Monitoring of CleanroomsRisk Issues Environmental Monitoring of Cleanrooms
Risk Issues Environmental Monitoring of Cleanrooms
 
Pipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. AsifPipette Calibration Worksheet & Guidelines -M. Asif
Pipette Calibration Worksheet & Guidelines -M. Asif
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 

Viewers also liked

Cleanroom sop slides
Cleanroom sop slidesCleanroom sop slides
Cleanroom sop slides
Tim Sandle, Ph.D.
 
Cleanroom history
Cleanroom historyCleanroom history
Cleanroom history
Tim Sandle, Ph.D.
 
Black Death and plague: a new understanding
Black Death and plague: a new understandingBlack Death and plague: a new understanding
Black Death and plague: a new understanding
Tim Sandle, Ph.D.
 
The Black death - a re-emerging infectious disease
The Black death - a re-emerging infectious diseaseThe Black death - a re-emerging infectious disease
The Black death - a re-emerging infectious disease
Tim Sandle, Ph.D.
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operation
Tim Sandle, Ph.D.
 
Developments in regulatory requirements
Developments in regulatory requirements Developments in regulatory requirements
Developments in regulatory requirements
Tim Sandle, Ph.D.
 
Myths of pharmaceutical microbiology
Myths of pharmaceutical microbiologyMyths of pharmaceutical microbiology
Myths of pharmaceutical microbiology
Tim Sandle, Ph.D.
 
USP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on MicrobiologyUSP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on Microbiology
Tim Sandle, Ph.D.
 
Sterility assurance
Sterility assuranceSterility assurance
Sterility assurance
Tim Sandle, Ph.D.
 
Lal presentation
Lal presentation Lal presentation
Lal presentation
Tim Sandle, Ph.D.
 
ISO 14644 - introducing the revised standard
ISO 14644 - introducing the revised standardISO 14644 - introducing the revised standard
ISO 14644 - introducing the revised standard
Tim Sandle, Ph.D.
 
EU GMP Annex1 Review
EU GMP Annex1 ReviewEU GMP Annex1 Review
EU GMP Annex1 Review
Tim Sandle, Ph.D.
 
A summary of pharmaceutical microbiology part 2 - drugs
A summary of pharmaceutical microbiology   part 2 - drugsA summary of pharmaceutical microbiology   part 2 - drugs
A summary of pharmaceutical microbiology part 2 - drugs
NES
 

Viewers also liked (13)

Cleanroom sop slides
Cleanroom sop slidesCleanroom sop slides
Cleanroom sop slides
 
Cleanroom history
Cleanroom historyCleanroom history
Cleanroom history
 
Black Death and plague: a new understanding
Black Death and plague: a new understandingBlack Death and plague: a new understanding
Black Death and plague: a new understanding
 
The Black death - a re-emerging infectious disease
The Black death - a re-emerging infectious diseaseThe Black death - a re-emerging infectious disease
The Black death - a re-emerging infectious disease
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operation
 
Developments in regulatory requirements
Developments in regulatory requirements Developments in regulatory requirements
Developments in regulatory requirements
 
Myths of pharmaceutical microbiology
Myths of pharmaceutical microbiologyMyths of pharmaceutical microbiology
Myths of pharmaceutical microbiology
 
USP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on MicrobiologyUSP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on Microbiology
 
Sterility assurance
Sterility assuranceSterility assurance
Sterility assurance
 
Lal presentation
Lal presentation Lal presentation
Lal presentation
 
ISO 14644 - introducing the revised standard
ISO 14644 - introducing the revised standardISO 14644 - introducing the revised standard
ISO 14644 - introducing the revised standard
 
EU GMP Annex1 Review
EU GMP Annex1 ReviewEU GMP Annex1 Review
EU GMP Annex1 Review
 
A summary of pharmaceutical microbiology part 2 - drugs
A summary of pharmaceutical microbiology   part 2 - drugsA summary of pharmaceutical microbiology   part 2 - drugs
A summary of pharmaceutical microbiology part 2 - drugs
 

Similar to Application of microbiological data

Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Aamir Ijaz Brig
 
Statistical Process Control
Statistical Process ControlStatistical Process Control
Statistical Process Control
Tushar Naik
 
quality control in clinical laboratory
quality control in clinical laboratory quality control in clinical laboratory
quality control in clinical laboratory
DrmanarEmam
 
ME 313 Mechanical Measurements and Instrumentation Lecture 01
ME 313 Mechanical Measurements and Instrumentation Lecture 01ME 313 Mechanical Measurements and Instrumentation Lecture 01
ME 313 Mechanical Measurements and Instrumentation Lecture 01
Dr. Bilal Siddiqui, C.Eng., MIMechE, FRAeS
 
Clinical lab qc sethu
Clinical lab qc sethuClinical lab qc sethu
Clinical lab qc sethu
subramaniam sethupathy
 
Spc methods
Spc methods Spc methods
Spc methods
Sudarshana26
 
Statistical Process Control Part 1
Statistical Process Control Part 1Statistical Process Control Part 1
Statistical Process Control Part 1
Malay Pandya
 
Chapter 12
Chapter 12Chapter 12
Chapter 12
ECRD IN
 
Quality Assurance and Quality Control
Quality Assurance and Quality ControlQuality Assurance and Quality Control
Quality Assurance and Quality Control
ECRD IN
 
Quality assurance and quality control
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality control
ECRD2015
 
Qc and qa
Qc and qaQc and qa
Qc and qa
Zahid Chughtai
 
MSA R&R for training in manufacturing industry
MSA R&R for training in manufacturing industryMSA R&R for training in manufacturing industry
MSA R&R for training in manufacturing industry
abhishek558363
 
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Gabor Szabo, CQE
 
SPC Presentation.pptx
SPC Presentation.pptxSPC Presentation.pptx
SPC Presentation.pptx
ssuserb1c139
 
CONTROL CHARTS
CONTROL CHARTSCONTROL CHARTS
CONTROL CHARTS
Meenakshi Singh
 
Troubleshooting IQC / EQAS
Troubleshooting IQC / EQASTroubleshooting IQC / EQAS
Troubleshooting IQC / EQAS
Dr. Bikash Kumar Chaudhury
 
Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018
Dr. Bikash Kumar Chaudhury
 
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptxANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
Dr. Jagroop Singh
 
4 26 2013 1 IME 674 Quality Assurance Reliability EXAM TERM PROJECT INFO...
4 26 2013 1 IME 674  Quality Assurance   Reliability EXAM   TERM PROJECT INFO...4 26 2013 1 IME 674  Quality Assurance   Reliability EXAM   TERM PROJECT INFO...
4 26 2013 1 IME 674 Quality Assurance Reliability EXAM TERM PROJECT INFO...
Robin Beregovska
 

Similar to Application of microbiological data (20)

Qc-gmp-qa
Qc-gmp-qaQc-gmp-qa
Qc-gmp-qa
 
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
 
Statistical Process Control
Statistical Process ControlStatistical Process Control
Statistical Process Control
 
quality control in clinical laboratory
quality control in clinical laboratory quality control in clinical laboratory
quality control in clinical laboratory
 
ME 313 Mechanical Measurements and Instrumentation Lecture 01
ME 313 Mechanical Measurements and Instrumentation Lecture 01ME 313 Mechanical Measurements and Instrumentation Lecture 01
ME 313 Mechanical Measurements and Instrumentation Lecture 01
 
Clinical lab qc sethu
Clinical lab qc sethuClinical lab qc sethu
Clinical lab qc sethu
 
Spc methods
Spc methods Spc methods
Spc methods
 
Statistical Process Control Part 1
Statistical Process Control Part 1Statistical Process Control Part 1
Statistical Process Control Part 1
 
Chapter 12
Chapter 12Chapter 12
Chapter 12
 
Quality Assurance and Quality Control
Quality Assurance and Quality ControlQuality Assurance and Quality Control
Quality Assurance and Quality Control
 
Quality assurance and quality control
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality control
 
Qc and qa
Qc and qaQc and qa
Qc and qa
 
MSA R&R for training in manufacturing industry
MSA R&R for training in manufacturing industryMSA R&R for training in manufacturing industry
MSA R&R for training in manufacturing industry
 
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
 
SPC Presentation.pptx
SPC Presentation.pptxSPC Presentation.pptx
SPC Presentation.pptx
 
CONTROL CHARTS
CONTROL CHARTSCONTROL CHARTS
CONTROL CHARTS
 
Troubleshooting IQC / EQAS
Troubleshooting IQC / EQASTroubleshooting IQC / EQAS
Troubleshooting IQC / EQAS
 
Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018Troubleshooting iqc eqas 19.07.2018
Troubleshooting iqc eqas 19.07.2018
 
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptxANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
ANALYTICAL VARIABLES IN QUALITY CONTROL.pptx
 
4 26 2013 1 IME 674 Quality Assurance Reliability EXAM TERM PROJECT INFO...
4 26 2013 1 IME 674  Quality Assurance   Reliability EXAM   TERM PROJECT INFO...4 26 2013 1 IME 674  Quality Assurance   Reliability EXAM   TERM PROJECT INFO...
4 26 2013 1 IME 674 Quality Assurance Reliability EXAM TERM PROJECT INFO...
 

More from Tim Sandle, Ph.D.

Reviewing environmental monitoring.ppt
Reviewing environmental monitoring.pptReviewing environmental monitoring.ppt
Reviewing environmental monitoring.ppt
Tim Sandle, Ph.D.
 
Open discussion on rapid microbiological methods.pptx
Open discussion on rapid microbiological methods.pptxOpen discussion on rapid microbiological methods.pptx
Open discussion on rapid microbiological methods.pptx
Tim Sandle, Ph.D.
 
Electronic Data Management Systems.ppt
Electronic Data Management Systems.pptElectronic Data Management Systems.ppt
Electronic Data Management Systems.ppt
Tim Sandle, Ph.D.
 
Risk management and environmental monitoring
Risk management and environmental monitoringRisk management and environmental monitoring
Risk management and environmental monitoring
Tim Sandle, Ph.D.
 
Audit efficiency storyboard.pptx
Audit efficiency storyboard.pptxAudit efficiency storyboard.pptx
Audit efficiency storyboard.pptx
Tim Sandle, Ph.D.
 
Anomalies, complaints and non-compliances
Anomalies, complaints and non-compliancesAnomalies, complaints and non-compliances
Anomalies, complaints and non-compliances
Tim Sandle, Ph.D.
 
Pharma micro myths (sandle)
Pharma micro myths (sandle)Pharma micro myths (sandle)
Pharma micro myths (sandle)
Tim Sandle, Ph.D.
 
Application of FMEA to a Sterility Testing Isolator: A Case Study
Application of FMEA to a Sterility Testing Isolator: A Case StudyApplication of FMEA to a Sterility Testing Isolator: A Case Study
Application of FMEA to a Sterility Testing Isolator: A Case Study
Tim Sandle, Ph.D.
 
Operation of Sterility Testing Isolators and validation issues
Operation of Sterility Testing Isolators and validation issuesOperation of Sterility Testing Isolators and validation issues
Operation of Sterility Testing Isolators and validation issues
Tim Sandle, Ph.D.
 
Pharmaceutical Microbiology: Current and Future Challenges
Pharmaceutical Microbiology: Current and Future Challenges Pharmaceutical Microbiology: Current and Future Challenges
Pharmaceutical Microbiology: Current and Future Challenges
Tim Sandle, Ph.D.
 
The selection and use of reference materials
The selection and use of reference materialsThe selection and use of reference materials
The selection and use of reference materials
Tim Sandle, Ph.D.
 
Sterility assurance and microbiology awareness
Sterility assurance and microbiology awarenessSterility assurance and microbiology awareness
Sterility assurance and microbiology awareness
Tim Sandle, Ph.D.
 
Introduction to GxP
Introduction to GxPIntroduction to GxP
Introduction to GxP
Tim Sandle, Ph.D.
 

More from Tim Sandle, Ph.D. (13)

Reviewing environmental monitoring.ppt
Reviewing environmental monitoring.pptReviewing environmental monitoring.ppt
Reviewing environmental monitoring.ppt
 
Open discussion on rapid microbiological methods.pptx
Open discussion on rapid microbiological methods.pptxOpen discussion on rapid microbiological methods.pptx
Open discussion on rapid microbiological methods.pptx
 
Electronic Data Management Systems.ppt
Electronic Data Management Systems.pptElectronic Data Management Systems.ppt
Electronic Data Management Systems.ppt
 
Risk management and environmental monitoring
Risk management and environmental monitoringRisk management and environmental monitoring
Risk management and environmental monitoring
 
Audit efficiency storyboard.pptx
Audit efficiency storyboard.pptxAudit efficiency storyboard.pptx
Audit efficiency storyboard.pptx
 
Anomalies, complaints and non-compliances
Anomalies, complaints and non-compliancesAnomalies, complaints and non-compliances
Anomalies, complaints and non-compliances
 
Pharma micro myths (sandle)
Pharma micro myths (sandle)Pharma micro myths (sandle)
Pharma micro myths (sandle)
 
Application of FMEA to a Sterility Testing Isolator: A Case Study
Application of FMEA to a Sterility Testing Isolator: A Case StudyApplication of FMEA to a Sterility Testing Isolator: A Case Study
Application of FMEA to a Sterility Testing Isolator: A Case Study
 
Operation of Sterility Testing Isolators and validation issues
Operation of Sterility Testing Isolators and validation issuesOperation of Sterility Testing Isolators and validation issues
Operation of Sterility Testing Isolators and validation issues
 
Pharmaceutical Microbiology: Current and Future Challenges
Pharmaceutical Microbiology: Current and Future Challenges Pharmaceutical Microbiology: Current and Future Challenges
Pharmaceutical Microbiology: Current and Future Challenges
 
The selection and use of reference materials
The selection and use of reference materialsThe selection and use of reference materials
The selection and use of reference materials
 
Sterility assurance and microbiology awareness
Sterility assurance and microbiology awarenessSterility assurance and microbiology awareness
Sterility assurance and microbiology awareness
 
Introduction to GxP
Introduction to GxPIntroduction to GxP
Introduction to GxP
 

Recently uploaded

Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
SĂŠrgio Sacani
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
SĂŠrgio Sacani
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 

Recently uploaded (20)

Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 

Application of microbiological data

  • 1. Applications of Microbiolgical Data Tim Sandle Microbiology information resource: http://www.pharmamicroresources.com/
  • 2. Introduction  Distribution of microbiological data  Use of trend charts  Calculation of warning and action levels
  • 3. Introduction  Examples from environmental monitoring and water testing  Broad and illustrative overview  Written paper with more detail
  • 4. Distribution of microbiological data  Why study distribution? • Impact on sampling • Impact on trending • Impact upon calculation of warning and action levels
  • 5. Distribution  Most statistical methods are based on normal distribution, and yet….  Most microbiological data does NOT follow normal distribution
  • 6. Distribution  Micro-organisms, such as those in a typical, free-flowing water system, follow Poisson distribution  For example…
  • 7. Distribution S1 S2 S3 S4 S5 Where S = sample = micro-organism
  • 8. Distribution  And microbial counts tend to be skewed (or positive or negative exponential distribution)  For example, a Water-for-Injection system…
  • 9. Distribution Typical distribution of micro-organisms in WFI 0 50 100 150 200 250 300 350 1 2 3 4 5 6 7 Count (cfu / 100 ml) Numberofsamples
  • 10. Distribution  So, what can we do about it? Skewed question mark
  • 11. Distribution  Well: a) Use complex calculations and Poisson distribution tables, or b) Attempt to transform then data  We’ll go for the second option
  • 12. Distribution  A general rule is: • For low count data e.g. Grade A monitoring and WFI systems, take the square root • For higher count data, e.g. Grade C and D environmental monitoring or a purified water system, convert the data into logarithms
  • 13. Distribution  For example, some counts from a WFI system:
  • 14. Distribution  When the data is examined for its distribution, using a simple ’blob’ chart: CI for Mean 0 2 4 6 8 Count
  • 15. Distribution  Whereas if the square root is taken:
  • 16. Distribution  We move closer to normal distribution: CI for Mean 0 0.5 1 1.5 2 2.5 3 Count
  • 17. Distribution  Logarithms work in a similar way for higher counts  Remember to add ‘+1’ to zero counts (and therefore, +1 to all counts)
  • 18. Trend Analysis  There is no right or wrong approach  There are competing systems  This presentation focuses on two approaches, both described as ‘control charts’: • The cumulative sum chart • The Shewhart chart
  • 19. Trend Analysis  Control charts form part of the quality system  They can be used to show: • Excessive variations in the data • How variations change with time • Variations that are ‘normally’ expected • Variations that are unexpected, i.e. something unusual has happened
  • 20. Trend Analysis  Control charts need: • A target value, e.g. last year’s average • Monitoring limits:  Upper limit  Lower limit  Control line / mean  So the data can be monitored over time and in relation to these limits
  • 21. Trend Analysis  Of these, • The warning limit is calculated to represent a 2.5% chance • The action level is calculated to represent a 0.1% chance • So, if set properly, most data should remain below these limits • These assumptions are based on NORMAL DISTRIBUTION • Various formula can be used to set these or validated software
  • 22. Trend Analysis  Cumulative sum chart (cusum) • Suitable for large quantities of low count data. It is very sensitive to small shifts • Shows shifts in the process mean  Shewhart chart • Suitable for higher count data. It shows large changes more quickly.
  • 23. Trend Analysis  Cusums • Harder to interpret • Displays the cumulative sum of a rolling average of three values and plots these in comparison with the target value • The direction and steepness of the slope are important • Significant changes are called ‘steps’ • V-masks can be used as a prediction to the future direction
  • 24. Trend Analysis  For example, a Grade B cleanroom  Contact (RODAC) plates are examined  A target of 0.2 cfu has been used, based on data from the previous year
  • 26. Trend Analysis  Shewhart charts • Powerful for distinguishing between special causes and common causes • Common causes are inherent to the process and are long-term • Special causes are where something has changed and maybe of a long or short term
  • 27. Trend Analysis  Examples of special causes: • a) A certain process • b) A certain outlet • c) A certain method of sanitisation, etc. • d) Sampling technique • e) Equipment malfunction e.g. pumps, UV lamps • f) Cross contamination in laboratory • g) Engineering work • h) Sanitisation frequencies
  • 28. Trend Analysis  For example, a Grade C cleanroom • Active air-samples are examined • A target of 1.5, based on historical data
  • 30. Trend Analysis  The previous charts were prepared using a statistical software package  However, MS Excel can also be used  The next example is of a WFI system  Notice the data has been converted by taking the square root of each value
  • 31. Trend Analysis Trend of WFI System over 62 weeks with trend line -1 -0.5 0 0.5 1 1.5 2 2.5 3 3.5 1 5 9 13 17 21 25 29 33 37 41 45 49 53 57 61 Number of weeks Sqrootofmeancount/ week
  • 32. Trend Analysis  Alternatives: • Individual Value / Moving Range charts • Exponentially Weighted Moving Average charts (EWMA) • These are useful where counts are NOT expected, e.g. Grade A environments • They look at the frequency of intervals between counts
  • 33. Trend Analysis  Summary Chart Type Advantage Disadvantage Cumulative sum Cusum charts are more sensitive to small process shifts. Large, abrupt shifts are not detected as fast as in a Shewhart chart. Shewhart chart Systematic shifts are easily detected. The probability of detecting small shifts fast is rather small
  • 34. Limits  Alert and action levels  Based on PDA Tech. Report 13 (2001): • Alert level: a level, when exceeded, indicates that the process may have drifted from its normal operating condition. This does not necessarily warrant corrective action but should be noted by the user. • Action level: a level, when exceeded, indicates that the process has drifted from its normal operating range. This requires a documented investigation and corrective action.
  • 35. Limits  Why use them? • Assess any risk (which can be defined as low, medium or high) • To propose any corrective action • To propose any preventative action
  • 36. Limits  “Level” is preferable to “Limit”  Limits apply to specifications e.g. sterility test  Levels are used for environmental monitoring
  • 37. Limits  Regulators set ‘guidance’ values e.g. EU GMP; USP <1116>; FDA (2004)  These apply to new facilities  User is expected to set their own based on historical data • Not to exceed the published values • Many references stating this • Views of MHRA and FDA
  • 38. Limits  Things to consider: • The length of time that the facility has been in use for • How often the user intends to use the limits for (i.e. when the user intends to re-assess or re- calculate the limits. Is this yearly? Two yearly? And so on). • Custom and practice in the user’s organisation (e.g. is there a preferred statistical technique?) • They be calculated from an historical analysis of data. • Uses a statistical technique.
  • 39. Limits  Historical data • Aim for a minimum of 100 results • Ideally one year, to account for seasonal variations
  • 40. Limits  Statistical methods: • Percentile cut-off • Normal distribution • Exponential distribution • Non-parametric tolerance limits • Weibull distribution Recommended by PDA Technical Report, No. 13
  • 41. Limits  Assumptions: a) The previous period was ‘normal’ and that future excursions above the limits are deviations from the norm b) Outliers have been accounted for
  • 42. Limits  Percentile cut-off • Good for low count data • May need to use frequency tables • May need to round up or down to nearest whole zero or five • Warning level = 90th or 95th • Action level = 95th or 99th
  • 43. Limits  Percentile cut-off • Data is collected, sorted and ranked  90th percentile means that any future result that exceeds this is 90% higher than all of the results obtained over the previous year. • Refer to PharMIG News Number 3 (2000) for excellent examples.
  • 44. Limits  Normal distribution • Can only be used on data that is normally distributed! • Could transform data but inaccuracies can creep in • Most data will be one-tailed, therefore need to adjust 2nd and 3rd standard deviation  Warning level = 1.645 + the mean  Action level = 2.326 + the mean
  • 45. Limits  Negative exponential distribution • Suitable for higher count data • Warning level: 3.0 x mean • Action level: 4.6 x mean
  • 46. Limits  For all, do a ‘sore thumb’ activity by comparing to a histogram of the data  Does it feel right?
  • 47. Conclusion  We have looked at: • Distribution of microbiological data • Trending  Cusum charts  Shewhart charts • Setting warning and action levels  Percentile cut-off  Normal distribution approach  Negative exponential approach
  • 48. Conclusion  Key points: • Most micro-organisms and microbial counts do not follow normal distribution • Data can be transformed • Inspectors expect some trending and user defined monitoring levels • Don’t forget to be professional microbiologists – it isn’t all numbers!
  • 49. Just a thought…  This has been a broad over-view  If there is merit in a more ‘hands on’ training course, please indicate on your post-conference questionnaires.